Overview

Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the oral availability of a test product of Mycophenolate Mofetil 250 mg capsule to an equivalent oral dose of the commercially available reference product, CellCeptĀ® 250 mg capsule administered to healthy subjects under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Teva Pharmaceuticals USA
Treatments:
Mycophenolate mofetil
Mycophenolic Acid